| 1 | A prospective evaluation of neck and shoulder function following treatments of <scp>early‐stage</scp> human <scp>papillomavirus‐associated</scp> oropharynx cancer | 1.3 | 2 | Citations (PDF) |
| 2 | Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma | 2.4 | 5 | Citations (PDF) |
| 3 | Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion | 1.6 | 1 | Citations (PDF) |
| 4 | Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time | 4.1 | 19 | Citations (PDF) |
| 5 | STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer | 6.9 | 22 | Citations (PDF) |
| 6 | Patient‐Reported Quality of Life After Resection With Primary Closure for Oral Tongue Carcinoma | 1.5 | 17 | Citations (PDF) |
| 7 | Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer | 1.5 | 2 | Citations (PDF) |
| 8 | Sialendoscopy in Chronic Obstructive Sialadenitis Without Sialolithiasis: A Prospective Cohort Study | 2.4 | 13 | Citations (PDF) |
| 9 | Head and neck surgery during the coronavirus‐19 pandemic: The University of California San Francisco experience | 2.0 | 16 | Citations (PDF) |
| 10 | Patterns of Nodal Metastases and Predictors of Occult Disease in HPV‐Associated Oropharynx Cancer | 2.4 | 11 | Citations (PDF) |
| 11 | Predicting Adverse Histopathology and Need for Postsurgical Adjuvant Therapy for Human Papilloma Virus–Associated Oropharynx Carcinoma | 2.4 | 5 | Citations (PDF) |
| 12 | Obstructive Sialadenitis: Stones and Stenoses | 1.0 | 1 | Citations (PDF) |
| 13 | Impact of surgical margins on local control in patients undergoing <scp>single‐modality</scp> transoral robotic surgery for <scp>HPV‐related</scp> oropharyngeal squamous cell carcinoma | 2.0 | 41 | Citations (PDF) |
| 14 | Oncologic outcomes of human papillomavirus–associated oropharynx carcinoma treated with surgery alone: A 12‐institution study of 344 patients | 4.1 | 19 | Citations (PDF) |
| 15 | Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma | 1.6 | 8 | Citations (PDF) |
| 16 | A prospective study of <scp>patient‐reported xerostomia‐related</scp> outcomes after parotidectomy | 1.6 | 6 | Citations (PDF) |
| 17 | Transoral Excision of Parapharyngeal Space Tumors | 1.2 | 21 | Citations (PDF) |
| 18 | Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer | 3.1 | 19 | Citations (PDF) |
| 19 | Treatment modality impact on quality of life for human papillomavirus–associated oropharynx cancer | 1.5 | 42 | Citations (PDF) |
| 20 | Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma | 1.5 | 60 | Citations (PDF) |
| 21 | Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age | 2.5 | 23 | Citations (PDF) |
| 22 | Functional Specialization of Human Salivary Glands and Origins of Proteins Intrinsic to Human Saliva | 6.4 | 82 | Citations (PDF) |
| 23 | Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology | 2.0 | 40 | Citations (PDF) |
| 24 | Salivary Gland Neoplasms | 1.0 | 0 | Citations (PDF) |
| 25 | HPV-positive Squamous Cell Carcinoma of the Larynx, Oral Cavity, and Hypopharynx | 3.6 | 30 | Citations (PDF) |
| 26 | Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients | 2.0 | 5 | Citations (PDF) |
| 27 | Sex differences in HPV immunity among adults without cancer | 3.2 | 17 | Citations (PDF) |
| 28 | Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate‐risk features | 2.0 | 2 | Citations (PDF) |
| 29 | One‐year outcomes of sialendoscopic‐assisted salivary duct surgery for sialadenitis without sialolithiasis | 1.5 | 16 | Citations (PDF) |
| 30 | Advanced head and neck surgical techniques: A survey of US otolaryngology resident perspectives | 1.5 | 7 | Citations (PDF) |
| 31 | Socioeconomic disparities in a population of patients undergoing total thyroidectomy for benign disease | 2.0 | 4 | Citations (PDF) |
| 32 | Human Papillomavirus–Associated Oropharyngeal Cancer: Patterns of Nodal Disease | 2.4 | 24 | Citations (PDF) |
| 33 | Salivary glands regenerate after radiation injury through SOX2‐mediated secretory cell replacement | 7.2 | 116 | Citations (PDF) |
| 34 | Surgeon-performed ultrasound for the assessment of parotid masses | 1.6 | 12 | Citations (PDF) |
| 35 | Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma | 1.7 | 20 | Citations (PDF) |
| 36 | Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults | 4.1 | 149 | Citations (PDF) |
| 37 | Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas | 1.5 | 30 | Citations (PDF) |
| 38 | Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy | 2.0 | 30 | Citations (PDF) |
| 39 | The effect of submandibular gland preservation during level 1B neck dissection on postoperative xerostomia | 1.5 | 11 | Citations (PDF) |
| 40 | A Novel Approach to Oropharyngeal Foreign Body Removal | 2.4 | 5 | Citations (PDF) |
| 41 | Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer | 2.0 | 14 | Citations (PDF) |
| 42 | A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments | 39.5 | 921 | Citations (PDF) |
| 43 | Squamous Cell Carcinoma of the Soft Palate in the United States: A Population‐Based Study | 2.4 | 9 | Citations (PDF) |
| 44 | High-Yield Purification, Preservation, and Serial Transplantation of Human Satellite Cells | 4.5 | 69 | Citations (PDF) |
| 45 | Shorter interval between radiation therapy and salvage laryngopharyngeal surgery increases complication rates following microvascular free tissue transfer | 1.6 | 11 | Citations (PDF) |
| 46 | Does a Standalone Cancer Center Improve Head and Neck Microsurgical Outcomes? | 2.1 | 3 | Citations (PDF) |
| 47 | The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer | 4.1 | 210 | Citations (PDF) |
| 48 | A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer | 2.4 | 3 | Citations (PDF) |
| 49 | Chronic parotitis with multiple calcifications: Clinical and sialendoscopic findings | 1.5 | 13 | Citations (PDF) |
| 50 | Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method | 14.6 | 136 | Citations (PDF) |
| 51 | Transoral robotic surgery (TORS) for excision of a retropharyngeal intramuscular lipoma | 1.5 | 8 | Citations (PDF) |
| 52 | Surgeon‐Performed Ultrasound for Chronic Obstructive Sialadenitis Helps Predict Sialendoscopic Findings and Outcomes | 2.4 | 20 | Citations (PDF) |
| 53 | Salivary duct stenosis: Short‐term symptom outcomes after sialendoscopy‐assisted salivary duct surgery | 1.5 | 22 | Citations (PDF) |
| 54 | Identification and characterization of a rich population of CD34+ mesenchymal stem/stromal cells in human parotid, sublingual and submandibular glands | 3.5 | 30 | Citations (PDF) |
| 55 | Volumetric Growth of Cervical Schwannoma as a Predictor of Surgical Intervention | 2.4 | 5 | Citations (PDF) |
| 56 | Sialadenitis without sialolithiasis: Prospective outcomes after sialendoscopy‐assisted salivary duct surgery | 1.5 | 34 | Citations (PDF) |
| 57 | Earlier and more specific detection of persistent neck disease with diffusion‐weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma | 2.0 | 16 | Citations (PDF) |
| 58 | Neck Dissection Technique Commonality and Variance: A Survey on Neck Dissection Technique Preferences among Head and Neck Oncologic Surgeons in the American Head and Neck Society | 1.1 | 12 | Citations (PDF) |
| 59 | Sialendoscopy‐assisted surgery and the chronic obstructive sialadenitis symptoms questionnaire: A prospective study | 1.5 | 42 | Citations (PDF) |
| 60 | Benefits of Immediate Extubation Following Free Tissue Transfer for Head and Neck Reconstruction | 2.1 | 21 | Citations (PDF) |
| 61 | Anterolateral Thigh Adipofascial Flap: A New Option for Scalp Reconstruction | 2.1 | 10 | Citations (PDF) |
| 62 | The <scp>C</scp>hronic <scp>O</scp>bstructive <scp>S</scp>ialadenitis <scp>S</scp>ymptoms <scp>Q</scp>uestionnaire to assess sialendoscopy‐assisted surgery | 1.5 | 46 | Citations (PDF) |
| 63 | Clinicopathologic characteristics and outcomes of recurrent oropharyngeal squamous cell carcinoma | 1.6 | 0 | Citations (PDF) |
| 64 | Xanthogranuloma in the heavily irradiated low neck in a patient with head and neck cancer | 1.7 | 2 | Citations (PDF) |
| 65 | How, when, and from whom neck dissection operative technique is learned: An international survey on neck dissection education among head and neck oncologic surgeons | 1.6 | 3 | Citations (PDF) |
| 66 | The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma | 1.6 | 8 | Citations (PDF) |
| 67 | Elective Lymphadenectomy during Salvage for Locally Recurrent Head and Neck Squamous Cell Carcinoma after Radiation | 2.4 | 11 | Citations (PDF) |
| 68 | Surgeon-performed ultrasound and transfacial sialoendoscopy for complete parotid duct stenosis | 1.5 | 12 | Citations (PDF) |
| 69 | Intraoperative Tumor Localization With Surgeon-Performed Ultrasound-Guided Needle Dye Injection | 1.5 | 0 | Citations (PDF) |
| 70 | Intraoperative tumor localization with surgeon‐performed ultrasound‐guided needle dye injection | 1.5 | 26 | Citations (PDF) |